SLC6A3 and Insulin resistance: Specifically, insulin resistance has been reported to reduce both nigrostriatal dopamine release and dopamine clearance in the brain [28], whereas insufficient insulin secretion results in reduced dopamine transporter and tyrosine hydroxylase mRNA in the substantia nigra [29].